Joint BioRN and Ci3 Annual Conference at Merck in Darmstadt

Joint BioRN and Ci3 Annual Conference at Merck in Darmstadt

The BioRN Life Science Cluster Rhine-Neckar in Heidelberg and the Cluster for Individualized ImmuneIntervention (Ci3) in Mainz were the organizers of yesterday’s Joint BioRN & Ci3 Annual Conference 2018 titled “Immunotherapy and beyond – The next generation of cancer treatment“.
200 participants – members and partners of both clusters and other invited guests - gathered in Darmstadt at the premises of the host Merck to share knowledge about the latest research on cancer immunotherapy.

The participants from academia and industry enjoyed a high-quality program. In addition to the opening lecture by Luciano Rossetti, Global Head of Research and Development in Merck’s biopharmaceutical business, presentations included keynote lectures by Ugur Sahin, Managing Director Science and Research of the translational oncology institute TRON in Mainz, and Neil Gallagher, Head of Global Oncology Development at AbbVie. All in all, 14 scientists from research institutes, SMEs and large corporations - all of them members or partners of the two clusters - presented their latest research findings on therapeutic vaccination, cellular therapies, combination therapies or novel agents. 

Read the full press release available from the download section on the right.

Klick here to watch the conference video.